Identification of the factors that leads to pulmonary tuberculosis and identification of the factors that affect the treatment outcome.
- Conditions
- Health Condition 1: A150- Tuberculosis of lung
- Registration Number
- CTRI/2021/04/032908
- Lead Sponsor
- Viramgami karan hiteshkumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
(1)Age more than 18 years.
(2)Patients with microbiologically confirmed cases (Sputum positive for AFB smear or CB-NAAT, BAL positive for AFB smear or culture or CB-NAAT) of pulmonary tuberculosis at the time of diagnosis
(3)Newly diagnosed patients or already diagnosed and on the anti-tubercular treatment having all previous investigations and treatment records
(4)Willing to participate and give consent
(1)Serological evidence of an acute infection with hepatitis B or C.
(2) Patient with HIV.
(3) Patients with malignancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cured from the diseaseTimepoint: End of 6months.
- Secondary Outcome Measures
Name Time Method Identification of adverse drug reactions of antitubercular drugs and identification of risk factors for pulmonary tuberculosis.Timepoint: End of 2nd month and 6months.